| 25-Hydroxyvitamin D 3 [nmol/L] |  | |
---|---|---|---|
 | Median | P 5, P 95 | P  b) |
Age < 76 years (n = 82) | 65.6 | 33.8 – 89.9 | 0.109 |
Age ≥ 76 years (n = 80) | 61.2 | 43.1 – 79.2 | |
Body mass index < 25 kg/m2 (n = 51) | 67.3 | 45.0 – 89.4 | 0.015 |
Body mass index ≥ 25 kg/m2 (n = 111) | 60.7 | 38.5 – 84.3 | |
Blood sampling in July/August (n = 102) | 61.6 | 38.0 – 84.1 | 0.280 |
Blood sampling in September (n = 60) | 66.0 | 44.5 – 90.0 | |
Vitamin D supplement non users (n = 145) | 62.9 | 39.7 – 87.2 | 0.239 |
Vitamin D supplement users (n = 17) | 67.4 | 32.8 – . | |
Intact parathyroid hormone ≤ 6.9 pmol/L (n = 138) | 64.2 | 45.3 – 88.5 | 0.001 |
Intact parathyroid hormone > 6.9 pmol/Lc) (n = 24) | 51.7 | 30.3 – 78.2 | |
eGFR < 60 mL/min/1.73 m2 (n = 99) | 61.4 | 39.6 – 87.3 | 0.297 |
eGFR ≥ 60 mL/min/1.73 m2 (n = 63) | 65.6 | 39.2 – 88.2 | |
Never-smokers (n = 100) | 64.0 | 39.6 – 88.8 | 0.162 |
Current or ex-smokers (n = 62) | 61.7 | 39.3 – 86.6 | |
Household income < 1500 €/month (n = 61) | 56.9 | 39.6 – 84.3 | 0.038 |
Household income ≥ 1500 €/month (n = 101) | 65.6 | 39.4 – 90.0 | |
Osteoporosis diagnosis/current medication (n = 52) | 64.3 | 39.9 – 91.7 | 0.346 |
No osteoporosis diagnosis/current medication (n = 110) | 62.2 | 38.5 – 85.0 |